Mesa Laboratories Q2 FY27 Backlog Shows Equity Growth
Mesa Laboratories reported 2.6% organic revenue growth to $62.3 million in Q2 FY27 and issued full-year revenue guidance of $250M-$255M. CEO Siddhartha Kadia highlighted the company's progress in operational execution while reducing net leverage.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed